Susquehanna Fundamental Investments, LLC Galapagos Nv Transaction History

Susquehanna Fundamental Investments, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$47.03 - $57.12 $1.34 Million - $1.63 Million	-28,551 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$52.17 - $70.2 $392,579 - $528,255	-7,525 Reduced 20.86%	28,551 $1.5 Million
Q2 2021 Aug 11, 2021	BUY	$68.86 - $83.34 $2.29 Million - $2.77 Million	33,276 Added 1188.43%	36,076 $2.49 Million
Q1 2021 May 17, 2021	BUY	$76.15 - $111.94 $213,220 - $313,432	2,800 New	2,800 $216,000

12.3M

69.1K

42.7K

Ticker GLPG
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,835,500
Market Cap $1.76B
Description
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.